Online research website Research and Markets has released a report titled “The 2011 US Flow Cytometry Market”.
The report analyses the important problems that are faced by practicing flow cytometry in US and also talks about technological, demographic, economic, social and regulatory factors and about their impact on the market for the next five years. The report also forecasts sales and volumes for the next five years in commercial laboratories and hospitals in the US.
The website also provides a detailed analysis of existing instrumentation and diagnostic technologies and compares them with future developments. Potentially new instruments, auxiliary products and consumables have also been discussed. Existing and future suppliers of flow cytometry have also been discussed, covering aspects such as their marketing strategies, product portfolios, new R&D development, sales, collaborative agreements and general corporate strategies. Based on this analysis, the report also makes recommendations to businesses and suppliers about potential opportunities and strategies. Other areas that have been covered are the factors that are a hindrance to the market, the criteria for design for decentralised testing products and competitiveness of the market.
Some of the leading companies that have been studied include Bio-Rad, Abbott, Sysmex, Roche, Horiba, Becton Dickinson, Siemens, Iris, Dako, Nihon Kohden and Ortho-Clinical Diagnostics.